Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
31 03 2020
Historique:
received: 26 11 2019
accepted: 26 01 2020
pubmed: 31 1 2020
medline: 29 9 2020
entrez: 31 1 2020
Statut: epublish

Résumé

Crimean-Congo hemorrhagic fever virus (CCHFV) is the causative agent of the most widespread tick-borne viral infection in humans. CCHFV encodes a secreted glycoprotein (GP38) of unknown function that is the target of a protective antibody. Here, we present the crystal structure of GP38 at a resolution of 2.5 Å, which revealed a novel fold primarily consisting of a 3-helix bundle and a β-sandwich. Sequence alignment and homology modeling showed distant homology between GP38 and the ectodomain of Gn (a structural glycoprotein in CCHFV), suggestive of a gene duplication event. Analysis of convalescent-phase sera showed high titers of GP38 antibodies indicating immunogenicity in humans during natural CCHFV infection. The only protective antibody for CCHFV in an adult mouse model reported to date, 13G8, bound GP38 with subnanomolar affinity and protected against heterologous CCHFV challenge in a STAT1-knockout mouse model. Our data strongly suggest that GP38 should be evaluated as a vaccine antigen and that its structure provides a foundation to investigate functions of this protein in the viral life cycle.

Identifiants

pubmed: 31996434
pii: JVI.02005-19
doi: 10.1128/JVI.02005-19
pmc: PMC7108853
pii:
doi:

Substances chimiques

Antibodies, Viral 0
Glycoproteins 0
Intercellular Signaling Peptides and Proteins 0
STAT1 Transcription Factor 0
Stat1 protein, mouse 0
structural-GP protein, Bos taurus 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI132246
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI142777
Pays : United States

Informations de copyright

Copyright © 2020 Mishra et al.

Références

J Gen Virol. 2012 Mar;93(Pt 3):560-564
pubmed: 22090213
Acta Crystallogr D Biol Crystallogr. 2009 Jun;65(Pt 6):582-601
pubmed: 19465773
Epidemiol Infect. 1996 Jun;116(3):353-61
pubmed: 8666081
Nucleic Acids Res. 2015 Jul 1;43(W1):W389-94
pubmed: 25883141
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Comp Immunol Microbiol Infect Dis. 2018 Aug;59:24-31
pubmed: 30290884
Acta Crystallogr D Struct Biol. 2016 Mar;72(Pt 3):430-9
pubmed: 26960130
Indian J Med Res. 2009 Nov;130(5):514-9
pubmed: 20090098
Sci Rep. 2019 May 23;9(1):7755
pubmed: 31123310
Nucleic Acids Res. 2016 Jul 8;44(W1):W344-50
pubmed: 27166375
FEMS Microbiol Lett. 2016 Apr;363(8):
pubmed: 26976854
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
PLoS One. 2015 May 08;10(5):e0125760
pubmed: 25955315
Acta Crystallogr D Biol Crystallogr. 2002 Oct;58(Pt 10 Pt 2):1772-9
pubmed: 12351820
Epidemiol Infect. 2015 May;143(7):1451-6
pubmed: 25185583
Cell Host Microbe. 2019 Jan 9;25(1):39-48.e5
pubmed: 30629917
Bioinformatics. 2019 Dec 15;35(24):5326-5327
pubmed: 31263867
J Virol. 2007 Dec;81(23):13271-6
pubmed: 17898072
Am J Trop Med Hyg. 2016 May 4;94(5):1107-1122
pubmed: 26903607
J Virol. 2006 Jan;80(1):514-25
pubmed: 16352575
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):133-44
pubmed: 20124693
Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):18030-5
pubmed: 23071322
J Virol. 2003 Aug;77(16):8640-9
pubmed: 12885882
Int J Infect Dis. 2017 May;58:82-89
pubmed: 28259724
Viruses. 2016 Apr 21;8(4):106
pubmed: 27110812
Adv Virus Res. 2017;98:83-118
pubmed: 28433053
J Biol Chem. 2017 Mar 3;292(9):3900-3908
pubmed: 28077575
Sci Adv. 2019 Jul 10;5(7):eaaw9535
pubmed: 31309159
Acta Crystallogr D Biol Crystallogr. 2006 Sep;62(Pt 9):1002-11
pubmed: 16929101
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Curr Protoc Protein Sci. 2016 Nov 1;86:2.9.1-2.9.37
pubmed: 27801516
J Trop Med Hyg. 1991 Jun;94(3):166-8
pubmed: 2051522
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):271-81
pubmed: 21460445
Antiviral Res. 2013 Oct;100(1):159-89
pubmed: 23906741
Acta Crystallogr D Biol Crystallogr. 2013 Jul;69(Pt 7):1204-14
pubmed: 23793146
Virology. 2002 Nov 10;303(1):146-51
pubmed: 12482666
Methods Mol Biol. 2014;1079:105-16
pubmed: 24170397
Am J Trop Med Hyg. 1986 Mar;35(2):387-92
pubmed: 3082234
PLoS Negl Trop Dis. 2018 Jul 9;12(7):e0006598
pubmed: 29985929
J Virol. 2005 May;79(10):6152-61
pubmed: 15858000
PLoS Pathog. 2015 May 01;11(5):e1004879
pubmed: 25933376
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W320-4
pubmed: 24753421
Nat Commun. 2019 Feb 20;10(1):879
pubmed: 30787296
Antiviral Res. 2016 Feb;126:21-34
pubmed: 26695860

Auteurs

Akaash K Mishra (AK)

Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA.

Crystal L Moyer (CL)

Mapp Biopharmaceutical, San Diego, California, USA.

Dafna M Abelson (DM)

Mapp Biopharmaceutical, San Diego, California, USA.

Daniel J Deer (DJ)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.

Kamel El Omari (K)

Diamond Light Source, Harwell Science and Innovation Campus, Didcot, Oxfordshire, United Kingdom.

Ramona Duman (R)

Diamond Light Source, Harwell Science and Innovation Campus, Didcot, Oxfordshire, United Kingdom.

Leslie Lobel (L)

Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Julius J Lutwama (JJ)

Department of Arbovirology, Emerging and Re-emerging Infection, Uganda Virus Research Institute, Entebbe, Uganda.

John M Dye (JM)

US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA.

Armin Wagner (A)

Diamond Light Source, Harwell Science and Innovation Campus, Didcot, Oxfordshire, United Kingdom.

Kartik Chandran (K)

Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.

Robert W Cross (RW)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.

Thomas W Geisbert (TW)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.

Larry Zeitlin (L)

Mapp Biopharmaceutical, San Diego, California, USA.

Zachary A Bornholdt (ZA)

Mapp Biopharmaceutical, San Diego, California, USA.

Jason S McLellan (JS)

Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA jmclellan@austin.utexas.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH